Table 1.

Patient characteristics. Numbers are count (%) or mean ± S.D. unless otherwise indicated

Females, count (%)	6 (60%)
HLA-B27 positive, number (%)	9 (90%)
Age, years (mean ± SD)	38 ± 10.9
Disease duration since diagnosis, years (mean ± SD)	7.0 ± 10.2
Duration of symptoms, years (mean ± SD)	10.3 ± 10.4
BASDAI (0–10), mean (S.D.)	5.2 (0.9)
ASDAS (0–10), mean (S.D.)	3.3 (0.5)
BASMI (0–10), mean (S.D.)	2.7 (1.8)
BASFI (0–10), mean (S.D.)	3.4 (1.9)
CRP, median (IQR), mg/mL	11.4 (11.0)
Patient global disease activity (0–10), mean (S.D.)	6.3 (1.3)
Treatment type
NSAIDs, number (%)	6 (60)
Coxibs, number (%)	4 (40)